SACUBITRIL; VALSARTAN | A213728 | MACLEODS PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
NOVARTIS PHARMACEUTICALS CORPORATION v. MACLEODS PHARMACEUTICALS LTD. et al 3 patentsANDA 213728sacubitril/valsartan | D.N.J. | 2019-10-25 | Terminated 2019-11-19 | — |
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al 4 patentsANDA 213682, 213728, 213689sacubitril/valsartan | D. Del. | 2019-10-24 | Terminated 2025-07-17 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.